Boston Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.6M Buy
20,879
+5,087
+32% +$445K 0.08% 294
2019
Q2
$1.36M Sell
15,792
-23,047
-59% -$1.57M 0.07% 289
2019
Q1
$2.29M Buy
38,839
+1,080
+3% +$62.1K 0.12% 209
2018
Q4
$1.99M Sell
37,759
-55,056
-59% -$3.23M 0.12% 207
2018
Q3
$5.15M Sell
92,815
-39,269
-30% -$2.02M 0.22% 146
2018
Q2
$6.21M Buy
132,084
+12,263
+10% +$505K 0.16% 141
2018
Q1
$4.33M Sell
119,821
-15,314
-11% -$539K 0.11% 201
2017
Q4
$4.9M Sell
135,135
-4,348
-3% -$157K 0.11% 220
2017
Q3
$5.34M Buy
139,483
+21,185
+18% +$888K 0.12% 203
2017
Q2
$4.9M Buy
118,298
+98,413
+495% +$3.74M 0.11% 218
2017
Q1
$700K Sell
19,885
-6,815
-26% -$216K 0.02% 410
2016
Q4
$823K Buy
26,700
+9,870
+59% +$305K 0.02% 387
2016
Q3
$508K Buy
16,830
+3,075
+22% +$92.8K 0.01% 507
2016
Q2
$376K Buy
13,755
+3,540
+35% +$90.5K 0.01% 548
2016
Q1
$274K Hold
10,215
0.01% 603
2015
Q4
$289K Hold
10,215
0.01% 586
2015
Q3
$284K Sell
10,215
-720
-7% -$26K 0.01% 673
2015
Q2
$451K Buy
+10,935
New +$401K 0.02% 504

Other funds holding RGEN

Boston Advisors's RGEN Position: Q3 2019 in Review

Boston Advisors increased its Repligen (RGEN) stake by 32% in Q3 2019, buying an estimated $445K and bringing the position to 20,879 shares worth $1.6M. The position accounts for 0.08% of the portfolio, ranked #294.

Boston Advisors first reported a position in RGEN in Q2 2015 and has held it in 18 quarters since. The position peaked at $6.21M in Q2 2018. 303 funds tracked by Wall St. Rank hold RGEN as of Q3 2019.

  • Boston Advisors held 20,879 shares of Repligen worth $1.6M as of Q3 2019.
  • Boston Advisors bought 5,087 Repligen shares in Q3 2019, an estimated $445K.
  • Repligen made up 0.08% of Boston Advisors's portfolio in Q3 2019, its #294 holding.
  • Boston Advisors first reported a position in Repligen in Q2 2015 and has held it in 18 quarters since.
  • Boston Advisors's Repligen position peaked at $6.21M in Q2 2018.
  • 303 funds tracked by Wall St. Rank held Repligen as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.